Multistate Outbreak of Burkholderia cepacia Infections

The CDC is collaborating with the Food and Drug Administration (FDA), multiple state and local health departments, and healthcare facilities to investigate a multi-state outbreak of Burkholderia cepacia infections. These infections have occurred primarily in ventilated patients without cystic fibrosis and who are being treated in intensive care units. A CDC July 8, 2016 update continues to recommend that clinicians not use any liquid docusate product as a stool softener or for any other medical purpose.

The recommendation has expanded from not using liquid docusate products for patients who are critically ill, ventilated, or immunosuppressed to all patient populations. Read more.